We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$4.36B
AUM Growth
+$1.15B
Cap. Flow
+$991M
Cap. Flow %
22.7%
Top 10 Hldgs %
14.65%
Holding
1,807
New
1,048
Increased
148
Reduced
170
Closed
353

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$66.5M
2
XOM icon
ExxonMobil
XOM
+$54.9M
3
AAPL icon
Apple
AAPL
+$52.1M
4
HMSY
HMS Holdings Corp.
HMSY
+$48.4M
5
ORCL icon
Oracle
ORCL
+$42.3M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 14.66%
3 Consumer Discretionary 14.56%
4 Financials 10.08%
5 Industrials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESS icon
1076
Essex Property Trust
ESS
$18.9B
$294K 0.01%
+981
New +$289K
NYMX
1077
DELISTED
Nymox Pharmaceutical Corp
NYMX
$294K 0.01%
+186,210
New +$345K
FAST icon
1078
Fastenal
FAST
$54B
$293K 0.01%
+11,286
New +$294K
LAUR icon
1079
Laureate Education
LAUR
$5.18B
$293K 0.01%
20,200
-19,100
-49% -$270K
MACAU
1080
DELISTED
Moringa Acquisition Corp Units
MACAU
$293K 0.01%
29,108
INVA icon
1081
Innoviva
INVA
$1.58B
$292K 0.01%
+21,800
New +$273K
KW
1082
DELISTED
Kennedy-Wilson Holdings
KW
$292K 0.01%
14,711
+2,784
+23% +$56.2K
BIOR
1083
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$292K 0.01%
+327
New +$250K
POLA icon
1084
Polar Power
POLA
$5.28M
$291K 0.01%
+4,435
New +$325K
AGRX
1085
DELISTED
Agile Therapeutics
AGRX
$291K 0.01%
+109
New +$359K
CSL icon
1086
Carlisle Companies
CSL
$13.6B
$290K 0.01%
+1,513
New +$281K
DYAI icon
1087
Dyadic International
DYAI
$43.4M
$290K 0.01%
+80,841
New +$339K
OTEX icon
1088
Open Text
OTEX
$5.43B
$290K 0.01%
+5,700
New +$276K
PCH
1089
DELISTED
PotlatchDeltic
PCH
$290K 0.01%
+5,458
New +$315K
LILAK icon
1090
Liberty Latin America Class C
LILAK
$1.5B
$289K 0.01%
22,550
+7,943
+54% +$102K
MODV
1091
DELISTED
ModivCare
MODV
$289K 0.01%
+1,700
New +$255K
SSL icon
1092
Sasol
SSL
$7.58B
$288K 0.01%
+18,797
New +$307K
TR icon
1093
Tootsie Roll Industries
TR
$2.82B
$288K 0.01%
+9,854
New +$278K
AGNC icon
1094
AGNC Investment
AGNC
$12.3B
$287K 0.01%
+16,983
New +$302K
DLB icon
1095
Dolby
DLB
$4.72B
$287K 0.01%
2,916
-14,872
-84% -$1.47M
RGNX icon
1096
Regenxbio
RGNX
$623M
$287K 0.01%
+7,400
New +$265K
ABGI
1097
DELISTED
ABG Acquisition Corp. I
ABGI
$287K 0.01%
29,126
MIME
1098
DELISTED
Mimecast Limited
MIME
$286K 0.01%
+5,384
New +$253K
REFR icon
1099
Research Frontiers
REFR
$16.1M
$285K 0.01%
+120,113
New +$299K
PSTX
1100
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$284K 0.01%
+28,300
New +$253K

Similar funds

Ergoteles's Q2 2021 Portfolio in Review

As of Q2 2021, Ergoteles held 1,807 positions worth $4.36B, up 36% from $3.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Ergoteles deployed $991M of net new capital in Q2 2021, opening 1,048 new positions and adding to 148 existing holdings. Its largest new stake was Linde: 174,841 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Walt Disney, an estimated $66.5M trimmed.

  • Ergoteles's largest Q2 2021 buy was Linde: 174,841 shares worth $50.5M.
  • Ergoteles added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $160M increase.
  • Ergoteles's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $66.5M.
  • Ergoteles fully exited ExxonMobil in Q2 2021, selling an estimated $54.9M.
  • Ergoteles's ten largest holdings make up 15% of its $4.36B portfolio in Q2 2021.
  • Ergoteles opened 1,048 new positions and closed 353 in Q2 2021.
  • Ergoteles's portfolio value rose 36% quarter-over-quarter to $4.36B.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.